Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2004-10-6
pubmed:abstractText
The aim of this study was to confirm clinically a hypothesis that cilostazol inhibits leukocyte Mac-1, leading to prevention of post-stent restenosis.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0735-1097
pubmed:author
pubmed:issnType
Print
pubmed:day
6
pubmed:volume
44
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1408-14
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:15464320-3',5'-Cyclic-AMP Phosphodiesterases, pubmed-meshheading:15464320-Aged, pubmed-meshheading:15464320-Coronary Angiography, pubmed-meshheading:15464320-Coronary Artery Disease, pubmed-meshheading:15464320-Coronary Restenosis, pubmed-meshheading:15464320-Cyclic Nucleotide Phosphodiesterases, Type 3, pubmed-meshheading:15464320-Female, pubmed-meshheading:15464320-Flow Cytometry, pubmed-meshheading:15464320-Humans, pubmed-meshheading:15464320-Leukocytes, pubmed-meshheading:15464320-Macrophage-1 Antigen, pubmed-meshheading:15464320-Male, pubmed-meshheading:15464320-Middle Aged, pubmed-meshheading:15464320-Neutrophils, pubmed-meshheading:15464320-P-Selectin, pubmed-meshheading:15464320-Platelet Activation, pubmed-meshheading:15464320-Platelet Aggregation Inhibitors, pubmed-meshheading:15464320-Research Design, pubmed-meshheading:15464320-Stents, pubmed-meshheading:15464320-Tetrazoles, pubmed-meshheading:15464320-Ticlopidine
pubmed:year
2004
pubmed:articleTitle
Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation.
pubmed:affiliation
Department of Cardiovascular and Renal Medicine, Saga University Faculty of Medicine, Saga, Japan. inouete@med.saga-uc.ac.jp <inouete@med.saga-uc.ac.jp>
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't